Federal Health Grants

This funding opportunity provides financial support to various organizations to develop and implement evidence-based self-management programs that improve health knowledge and reduce complications for individuals affected by blood disorders like hemophilia and thalassemia.

The U.S. Agency for International Development (USAID) invites interested Nigerian entities to participate in a pre-application conference for integrated Delivery of TB Services (iDOTS) Activity to be held on July 30, 2024 in Abuja. The purpose of the USAID/Nigeria integrated Delivery of TB Services (iDOTS) Activity is to reach every person with TB, cure those in need of treatment, prevent new infections and progression to active disease, while scaling-up innovations in detection, care, and treatment, and fostering local ownership to sustain TB programs that contribute to integrated primary health care services and pandemic preparedness in supported states.

The National Institute of Mental Health (NIMH) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications encouraging foundational research projects that seek to refine and test valid methods for characterizing preteen suicide risk and protective factors across multiple domains, and for operationalizing suicide thoughts and behavior (STBs) and nonsuicidal self-injury (NSSI) among preteen youth (ages 8-12). An emphasis is placed on the inclusion of sub-populations of youth that experience health disparities and may have been underrepresented in prior youth suicide research. Studies may focus on developing new or adapting developmentally and culturally appropriate methods for assessing and characterizing risk and protective factors, examining the acceptability and utility of existing assessment methods, evaluating the relevance of risk and protective factors for diverse preteen youth and their families, modeling risk-factor trajectories, and refining sampling strategies. The research projects funded through this announcement will participate in a research consortium with other R01 recipients. In addition, each research site will work with the Data Coordinating Center (DCC) site (supported by a companion announcement) to share and analyze data, recommend candidate measures that will be included as common data elements in future research and practice contexts,and identify optimal approaches for sampling individuals from underrepresented backgrounds. This Notice of Intent to Publish (NOITP) is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects, and to consult with NIH in order to submit responsive applications. The NOFO is expected to be published in Summer 2023, with an expected application due date in Fall 2023. This NOFO will utilize the R01 activity code. Details of the planned NOFO are provided below.

The National Center for Complementary and Integrative Health (NCCIH) with the Office of Dietary Supplements (ODS) solicit limited applications for continuation of an established nuclear magnetic resonance (NMR) research resource consisting of raw and meta-data from natural products ranging from crude extracts to purified substances; with the capacity to upload, download, store, search and analyze raw NMR data. The purpose of this limited competition is to promote sustainability, scaling and wider community inclusiveness of the established NMR research resource. This notice of funding opportunity (NOFO) is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and Leveraging Big Data to Understand Natural Product Impacts on Whole Person Health (R01).

The purpose of this Notice of Funding Opportunity (NOFO) is to support the establishment of one (1) Center of Excellence (CoE) to coordinate the research community of infectious and immune-mediated disease (IID) computational modelers and advance IID modeling research across biological scales. The CoE must include three (3) coordinating cores and two (2) research projects to advance and integrate bridge models across scales in the context of IID, including HIV/AIDS. The CoE will accelerate multi-scale model development, sharing and re-use, and support collaboration to benefit the entire IID research community.

This funding opportunity supports researchers and organizations in developing new small molecule therapies for mental and neurological disorders, focusing on innovative drug discovery methods without involving clinical trials.

This funding opportunity supports research projects that develop and implement effective strategies to reduce overdose deaths and improve addiction treatment across various settings, targeting diverse populations and addressing health disparities.

The "Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Limited Existing Geographic Service Areas" grant is a funding opportunity offered by the U.S. Department of Health and Human Services to support comprehensive health care and services for low-income individuals with HIV, particularly in underserved areas, with the aim of improving health outcomes and access to care.

This funding opportunity provides financial support for research focused on the long-term health outcomes of youth and young adults in the U.S. living with perinatally acquired HIV, emphasizing the impacts of antiretroviral therapy and associated health challenges.

This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the Scholar can be considered to remain as an investigator within the intramural program.

This funding opportunity provides financial support to a variety of organizations to strengthen public health systems in Cote d'Ivoire, focusing on improving disease detection, response, and prevention capabilities.

The "USAID Multi Sector Nutrition in the Democratic Republic of Congo" grant aims to improve nutrition outcomes, particularly for women of reproductive age and children under five, in rural and hard-to-reach communities in select provinces, by strengthening local capacity to coordinate and implement multi-sectoral initiatives that promote availability of diverse, nutritious foods, positive social and cultural norms, and integrated nutrition services.

This grant provides funding for researchers and organizations to develop innovative medical countermeasures for treating acute chemical exposures resulting from terrorist attacks or accidental releases, enhancing national preparedness for chemical emergencies.

This grant provides funding to U.S.-based educational institutions, nonprofits, and community organizations to improve mental health and substance use treatment practices in outpatient settings, particularly for underserved populations.

This grant provides funding for research projects that improve mental health services and outcomes for young people experiencing early stages of psychosis by promoting data-driven care and collaboration among specialized treatment programs across the United States.

This funding opportunity provides financial support for organizations to archive and document child health and human development data sets, facilitating their accessibility for secondary analysis by researchers.

The USAID THRIVE activity aims to contribute to achieving sustained epidemic control by improving the health and wellbeing of children living with HIV and reducing the risk of HIV infection among vulnerable children, adolescents, and caregivers. The activity will provide a suite of comprehensive services to build resilience and mitigate the multiple, layered vulnerabilities faced by these sub-populations. The target population for THRIVE activity is children and adolescents living with HIV (CALHIV), children whose caregivers are living with HIV (CPLHIV), HIV exposed infants (HEI), children of key populations (CKP), survivors of sexual violence against children (SVAC), and high-risk adolescent boys and girls, including out of school children.

This funding opportunity provides financial support for researchers and organizations developing innovative long-acting treatments for HIV and related co-infections, aiming to improve patient adherence and health outcomes.

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development and validation of reagents/tools to support research to characterize cellular and molecular constituents of the bat immune system and for the study of protective innate and adaptive immune mechanisms in bats. The Research Resource Program established by this NOFO will participate within a collaborative research network to advance understanding of the bat immune response. This NOFO will support the establishment and operation of a Bat Immunology Research Resource Program for the development and validation of reagents/tools for use in immunological studies using the bat model system. The recipient will participate in the Bat Immunology Network, which will consist of the Research Resource Program, the research projects supported by RFA-AI-23-068, and possible other participants as determined by NIAID. The Research Resource Program will conduct reagent/tool development and validation using appropriate systems, which includes testing against multiple bat species. While other members of the Bat Immunology Network may assist in validation efforts, reagent/tool validation is the responsibility of the Research Resource Program. Reagents/tools developed by the Research Resource Program will be provided to the research projects of the Bat Immunology Network. Reagents/tools will be made available to the broader research community through technology transfer arrangements, deposition to nonprofit repositories, and/or timely transfer to industry for commercialization. Areas of high priority include, but are not limited to, the development and validation of the following: Soluble immune molecules (e.g., cytokines, chemokines) for use in tissue culture or in vivo animal studies Antibodies or other probes/detection markers for use in cellular phenotyping, functional studies and/or immunoassays

This funding opportunity supports innovative research aimed at developing new strategies for curing HIV at the start of antiretroviral therapy, targeting researchers and institutions focused on reducing the HIV reservoir and improving immune responses.